LeMaitre Vascular, a company engaged in developing and manufacturing medical devices, has announced the commercial launch of the Tortuous Tracker, the next-generation introducer for LeMaitre Vascular’s aortic stent graft product lines.
The Tortuous Tracker (TT) system is designed to simplify stent graft implants by requiring reduced deployment force, providing the physician with increased control over placement of the stent graft in the aorta. The TT system offers better flexibility and an improved coating to increase maneuverability through blood vessels and a three-part valve system to minimize blood loss during the medical procedure. The TT system also provides better visualization during the procedure and a more ergonomic design.
Ryan Connelly, director of research & development of LeMaitre Vascular, said: The TT system should improve the ease of use and therefore the performance of our endovascular stent grafts. Since we acquired our stent graft product lines in 2005, we have carefully studied what vascular surgeons need to successfully deliver and deploy aortic stent grafts. The new TT system gives them what they have been asking for, which will enable better clinical results and improve patients’ lives.